Last reviewed · How we verify
evaluated vaccine
An evaluated vaccine formulation developed by Beijing CDC that stimulates immune response, though the specific antigen target and mechanism require clarification.
At a glance
| Generic name | evaluated vaccine |
|---|---|
| Sponsor | Beijing Center for Disease Control and Prevention |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Without additional specification of the vaccine type (inactivated, live attenuated, mRNA, protein subunit, viral vector, etc.) or target pathogen, the precise immunological mechanism cannot be accurately described. Vaccines generally work by presenting antigens to the immune system to generate adaptive immunity against specific infectious agents.
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine (PHASE1)
- Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (PHASE1)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults (PHASE3)
- DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection (PHASE1)
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination (PHASE2)
- Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults (PHASE1)
- Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- evaluated vaccine CI brief — competitive landscape report
- evaluated vaccine updates RSS · CI watch RSS
- Beijing Center for Disease Control and Prevention portfolio CI